Form4.ai tracks every SEC insider trade in real time. See every TXG insider filing with a free account — no card.
See every TXG insider filing — free account, no card.
Free account10x Genomics, Inc. (TXG) has 13 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 11 sales totalling $12.2M. Most recent filing: Sept. 24, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Sep 24, 2026 SEC filing | SULIMAN SHEHNAAZ Director | Sold | $464,668 | — |
| Sep 24, 2026 SEC filing | Saxonov Serge Chief Executive Officer | Sold | $2,030,562 | — |
| Sep 11, 2026 SEC filing | Taich Adam Chief Financial Officer | Sold | $2,995,470 | — |
Create a free account to see all 13 TXG filings from the last 90 days. No card needed.
Create free accountWant TXG insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.